Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

CSP5 vs CSPS


CSP5 — Amundi Core S&P 500 UCITS ETF Acc
IE000UBAW7M3 · Equity · United States · Large cap
CSPS — Amundi Core S&P 500 UCITS ETF Dist
IE0005OFGEA6 · equity
Open the interactive comparison on rebalix.com →

Comparison window: — · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 20 October 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixCSP5 vs CSPS · report of 20 October 2026

The funds at a glance

From official issuer documents and the ESMA register
CSP5IE000UBAW7M3Amundi Core S&P 500 UCITS ETF AccEquity · United States · Large cap
Declared index
S&P 500 Net Total Return Index
TER
0.03%
Transaction (KID)
0.01%
Fund size
23 mln EUR
Launch
10 Apr 2025
Currency
USD
Replication
Physical
Hedging
No
Holdings
504
Distributions 12m
acc.
Effective 🇮🇹 rate
26.00%
CSPSIE0005OFGEA6Amundi Core S&P 500 UCITS ETF Distequity
Declared index
S&P 500 Net Total Return Index
TER
0.03%
Transaction (KID)
—
Fund size
0 mln EUR
Launch
22 Sept 2026
Currency
USD
Replication
Physical
Hedging
No
Holdings
—
Distributions 12m
n/a
Effective 🇮🇹 rate
26.00%

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
CSP5n/d
not honestly computable
—
CSPSn/d
not honestly computable
—
Rebalix · CSP5 vs CSPSsection 1 of 2
RebalixCSP5 vs CSPS · report of 20 October 2026

Full comparison table

"—" = not published by the source, never estimated
CSP5 — Amundi Core S&P 500 UCITS ETF Acc · IE000UBAW7M3 · Equity · United States · Large cap
CSPS — Amundi Core S&P 500 UCITS ETF Dist · IE0005OFGEA6 · equity
MetricCSP5CSPSNote
Identity
CategoryEquity · United States · Large capequityRebalix engine classification
ReplicationPhysicalPhysicalas declared by the issuer
Currency hedgingNoNosource: class name, factsheet
Income policyaccumulatingdistributing—
Costs
TER0.03%0.03%as declared by the issuer
Transaction costs (KID)0.01%—internal
All-in cost0.04%0.03%declared annual cost + transaction (KID)
Tracking difference (3a)——vs its OWN index
Performance in euro (ECB rates)
1 year+19.7%——
3 years———
5 years———
10 years——— = series younger than the window
Risk · last 3 years
Volatility (ann.)———
Max drawdown———
Sharpe——risk-free = ECB MRO avg
Sortino——like Sharpe, downside only
Distributions (fund currency)
Frequencyaccumulating classhistory not available—
Distributions, last 12 monthsaccumulating classhistory not availableper share
Distribution yieldaccumulating classhistory not available12 months / NAV
Last ex-dateaccumulating classhistory not available—
Italian taxation
Effective capital-gains rate26.00%26.00%white list, current half-year
Documents & exchanges
Listing venues1—ESMA register
Borsa Italiana ticker———
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~26 euro CSP5 · ~19 euro CSPS. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · CSP5 vs CSPSsection 2 of 2